| 1 |
Mitochondria transfer via tunneling nanotubes is an important mechanism by which CD133+scattered tubular cells eliminate hypoxic tubular cell injury
Zou XY, Hou YP, Xu JX, Zhong L, Zhou J, Zhang GY, Sun J
Biochemical and Biophysical Research Communications, 522(1), 205, 2020 |
| 2 |
Inhibition of NOTCH signaling pathway chemosensitizes HCC CD133(+) cells to vincristine and 5-fluorouracil through upregulation of BBC3
Hemati H, Kaur J, Sobti RC, Trehanpati N
Biochemical and Biophysical Research Communications, 525(4), 941, 2020 |
| 3 |
Development and characterization of cancer stem cell-based tumoroids as an osteosarcoma model
Ozturk S, Gorgun C, Gokalp S, Vatansever S, Sendemir A
Biotechnology and Bioengineering, 117(8), 2527, 2020 |
| 4 |
Characterization and optimization of immunoaffinity aqueous two-phase systems with PEGylated CD133/2-biotin antibody in route to stem cell separation
Ornelas-Gonzalez A, Reisenauer SU, Gonzalez-Gonzalez M, Rito-Palomares M
Journal of Chemical Technology and Biotechnology, 95(1), 123, 2020 |
| 5 |
CD133 promotes the self-renewal capacity of thyroid cancer stem cells through activation of glutamate aspartate transporter SLC1A3 expression
Wang C, Wang ZL, Liu W, Ai ZL
Biochemical and Biophysical Research Communications, 511(1), 87, 2019 |
| 6 |
Activated STAT3 may participate in tumor progression through increasing CD133/survivin expression in early stage of colon cancer
Li W, Lee MR, Kim T, Kim YW, Cho MY
Biochemical and Biophysical Research Communications, 497(1), 354, 2018 |
| 7 |
Hypomyelination and cognitive impairment in mice lacking CD133 (Prominin-1)
Choi MH, Na JE, Yoon YR, Rhyu IJ, Ko YG, Baik JH
Biochemical and Biophysical Research Communications, 502(3), 291, 2018 |
| 8 |
Effect of long non-coding RNA H19 on oxidative stress and chemotherapy resistance of CD133+cancer stem cells via the MAPK/ERK signaling pathway in hepatocellular carcinoma
Ding K, Liao YN, Gong DH, Zhao X, Ji W
Biochemical and Biophysical Research Communications, 502(2), 194, 2018 |
| 9 |
A cancer/testis antigen, NY-SAR-35, induces EpCAM, CD44, and CD133, and activates ERK in HEK293 cells
Song MH, Kim YR, Bae JH, Shin DH, Lee SY
Biochemical and Biophysical Research Communications, 484(2), 298, 2017 |
| 10 |
Preliminary identification of endometrial cancer stem cells in vitro and in vivo
Kong FF, Li D, Yang H, Ma J, Pan X, Liu HX, Huo JN, Ma XX
Biochemical and Biophysical Research Communications, 490(2), 506, 2017 |
